Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

The Lancet

Volumn 372, Issue 9651, 2008, Pages 1733-1745

  Mathers, Bradley M ^a   Degenhardt, Louisa ^a,b   Phillips, Benjamin ^b   Wiessing, Lucas ^c   Hickman, Matthew ^d   Strathdee, Steffanie A ^e   Wodak, Alex ^a,b,f   Panda, Samiran ^g   Tyndall, Mark ^h   Toufik, Abdalla ⁱ   Mattick, Richard P ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f ST VINCENT S HOSPITAL   (Australia)

^g INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^h BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

ⁱ French Monitoring Centre for Drugs and Drug Addiction (OFDT)   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CHINA; GEOGRAPHIC DISTRIBUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; PEER REVIEW; PREVALENCE; PRIORITY JOURNAL; RUSSIAN FEDERATION; SYSTEMATIC REVIEW; UNITED STATES; VIRUS TRANSMISSION;

EID: 55749095381     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(08)61311-2     Document Type: Article

References (22)

1. UNAIDS . 2006 report on the global AIDS epidemic (2006), Joint UN Programme on HIV/AIDS, Geneva
2. Degenhardt L., Hall W., Lynskey M., and Warner-Smith M. Chapter 13: Illicit drug use. In: Ezzati M., Lopez A.D., Rodgers A., and Murray C.J.L. (Eds). Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. 2nd edn. (2004), World Health Organization, Geneva
3. Ezzati M., Lopez A.D., Rodgers A., Vander Hoorn S., Murray C.J.L., and for the Comparative Risk Assessment Collaborating Group . Selected major risk factors and global and regional burden of disease. Lancet 360 (2002) 1347-1360
4. Amorim C., Dlamini-Zuma N., Douste-Blazy P., et al. Oslo Ministerial Declaration-global health: a pressing foreign policy issue of our time. Lancet 369 (2007) 1373-1378
5. Murray C.J.L., and Frenk J. Health metrics and evaluation: strengthening the science. Lancet 371 (2008) 1191-1199
6. Aceijas C., Stimson G.V., Hickman M., and Rhodes T. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS 18 (2004) 2295-2303
7. Hickman M., and Taylor C. Indirect methods to estimate prevalence. In: Sloboda Z. (Ed). Epidemiology of drug abuse (2005), Springer Science & Business Media, New York
8. Hall W.D., Ross J.E., Lynskey M.T., Law M.G., and Degenhardt L.J. How many dependent heroin users are there in Australia?. Med J Aust 173 (2000) 528-531
9. Magnani R., Sabin K., Saidel T., and Heckathorn D. Review of sampling hard-to-reach and hidden populations for HIV surveillance. AIDS 19 suppl 2 (2005) S67-S72
10. UN Population Division . World population prospects: the 2006 revision (2007), United Nations, New York
11. Lu F., Wang N., Wu Z., et al. Estimating the number of people at risk for and living with HIV in China in 2005: methods and results. Sex Transm Infect 82 suppl 3 (2006) S87-S91
12. Borschevskaya V., and Tumano M. Country report of the Russian Federation on the implementation of the Declaration of Commitment on HIV/AIDS (UNGASS). January-December 2005 (2006), Federal Services for Surveillance of Consumer Rights and Welfare of Russian Federation, Moscow
13. Ball A.L., Rana S., and Dehne K.L. HIV prevention among injecting drug users: responses in developing and transitional countries. Public Health Reports 113 (1998) 12
14. International Narcotics Control Board . Report of the International Narcotics Control Board for 2007 (2008), United Nations, Vienna
15. UNODC . World drug report (2007), Office on Drugs and Crime, Vienna: UN
16. Renton A., Gzirishvilli D., Gotsadze G., and Godinho J. Epidemics of HIV and sexually transmitted infections in central Asia: trends, drivers and priorities for control. Int J Drug Pol 17 (2006) 494-503
17. Buvé A., Bishikwabo-Nsarhaza K., and Mutangadura G. The spread and effect of HIV-1 infection in sub-Saharan Africa. Lancet 359 (2002) 7
18. EMCDDA . 2007 annual report: the state of the drugs problem in Europe (2007), European Monitoring Centre for Drugs and Drug Addiction, Lisbon
19. National Centre in HIV Epidemiology and Clinical Research . Australian NSP survey national data report 2003-2007: prevalence of HIV, HCV and injecting and sexual behaviour among IDUs at needle and syringe programs (2008), University of New South Wales, Sydney
20. Sendziuk P. Harm reduction and HIV-prevention among injecting drug users in Australia: an international comparison. Can Bull Med Hist 24 (2007) 17
21. Calabria B., Phillips B., Singleton J., et al. Searching the grey literature to access information on drug and alcohol research. NDARC Technical Report No. 293 (2008), National Drug and Alcohol Research Centre, Sydney
22. UN . Declaration of commitment on HIV/AIDS. UN General Assembly Special Session on HIV/AIDS (2001), United Nations, New York